China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1
Approval may also benefit the Chinese healthcare system, among others through implementation. | November 28, 2022
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Committee for Medicinal Products for Human Use recommends approval of Kapruvia® as first therapy in Europe for the treatment of chronic kidney. | February 28, 2022
By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia s CSL Ltd. that values the company at $11.7 billion. At 0812 GMT,. | December 14, 2021
Vifor Pharma s shares
surged more than 15% in early trading on Monday after
the Swiss drugmaker and Australia s CSL both confirmed
they were talking about a potential merger. Australian. | December 13, 2021